Gene: SLAIN1
Official Full Name: SLAIN motif family member 1provided by HGNC
Gene Summary: Predicted to be involved in cytoplasmic microtubule organization; microtubule nucleation; and positive regulation of microtubule polymerization. Predicted to be located in microtubule plus-end. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28960 | SLAIN1 Knockout cell line (HeLa) | Human | SLAIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO28961 | SLAIN1 Knockout cell line (HEK293) | Human | SLAIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO28962 | SLAIN1 Knockout cell line (A549) | Human | SLAIN1 | 1:3~1:4 | Negative | Online Inquiry |
SLAIN1 Gene Knockout Cell Lines are an essential tool for researchers studying the SLAIN1 gene, which is implicated in various cellular processes, including microtubule dynamics and cytoskeletal organization. By providing cellular models in which the SLAIN1 gene has been selectively inactivated, these knockout cell lines facilitate in-depth investigations into the gene’s role within normal biological functions and disease states, such as cancer and neurodegenerative disorders.
The primary mechanism of action involves the use of CRISPR-Cas9 gene-editing technology to generate precise deletions in the SLAIN1 gene. This allows researchers to observe phenotypic changes and assess the molecular pathways affected by the absence of SLAIN1, thus elucidating its function in cellular motility, division, and signaling pathways. Researchers can utilize these knockout cell lines for a multitude of assays, including proliferation, migration, and invasion studies, which are critical for understanding disease mechanisms.
The scientific significance of SLAIN1 Gene Knockout Cell Lines extends to both research and clinical settings. They serve as invaluable models for drug screening and therapeutic intervention studies, allowing researchers to develop targeted treatments based on the specific mechanisms of diseases linked to SLAIN1 dysfunction. Compared to alternative models, such as overexpression or knockdown approaches, knockout lines provide a more accurate representation of loss-of-function scenarios, yielding clearer insights into the gene's biological relevance.
One of the key advantages of using these knockout cell lines is their reliability and reproducibility. Researchers can obtain consistent results across multiple experiments, thereby enhancing the credibility of their findings. Additionally, these models are readily available and easy to use, allowing for swift integration into ongoing research programs.
In conclusion, SLAIN1 Gene Knockout Cell Lines represent a powerful asset for both fundamental and translational research. By investing in this product, researchers and clinicians can advance their understanding of cellular processes and genetic disorders. Our company, with its strong foundation in genetic engineering and commitment to quality, offers these cell lines backed by comprehensive technical support and resources to assist in your scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.